Issued Vaccine Lots

FDA Lot-Release Authorizations

These memos show the authority for the manufacturer to release anthrax vaccine from the manufacturing plant. Each lot of every vaccine produced in the United States must be individually released in this way, after having been tested for sterility, purity, potency, and general safety. Lot-release tests are performed by the manufacturer and audited by FDA. View Pre-Renovation Lots
View All Issued Vaccine Lots
FAV111 PDF 17 Mar 05
FAV114 PDF 17 Mar 05
FAV113 PDF 22 Feb 05
FAV112 PDF 15 Feb 05
FAV107 PDF 27 Dec 04
FAV099 PDF 14 Oct 04